Accelerating Data Solutions to Save LIVES from COVID-19

The consortium of COVID-X announces the launch of the ​1st Open Call ​framed in a ​2-year initiative that will invest ​4 million € to fast-track to market 30+ European data technology solutions defeating COVID-19 Challenges, facilitating an innovative stack of AI-driven tools.

COVID-19 pandemic is hitting with force. Europe has passed the threshold of ​250,000 deaths since February 2020.​ COVID-X takes the battle against corona virus to a new level by bridging the gap between the European digital sector and the healthcare system. The program will unlock the full capacity of Artificial Intelligence and Data to fight COVID-19​, validating, and scaling up breakthroughs to save lives.

COVID-X will fund EU Companies and Healthcare Providers to boost data-driven solutions with the power to overcome challenges in Diagnosis, Prognosis, and Follow-up. The funding is invested in products with TRL7+ and [or in the process of] CE marking, covering two profiles: single players (EU Tech SMEs / Start-Ups) validating their solutions at one of COVID-X clinical partners; or ​multiplayers (Tech Provider working with a Healthcare provider that will validate the solution). The selected projects will join an Acceleration Program to boost their quick market uptake. ​This will include technical support, ethical validation, and business coaching.

In addition, participants will have access to the ​COVID-X Sandbox​, a one-stop platform to exploit COVID-19 data sources, incorporating general information on data silos, as well as the integration, visualization, and exploratory analysis for easy understanding. The 1st Open Call Application is now open and the deadline will be on​ the 27th January 2021.

For further information, please visit:
https://www.covid-x.eu

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...